These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7662077)

  • 1. [Immunohistochemical detection of c-myc proto-oncogene products in middle ear cholesteatoma].
    Holly A; Sittinger M; Bujía J
    Laryngorhinootologie; 1995 Jun; 74(6):348-51. PubMed ID: 7662077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
    Holly A; Sittinger M; Bujia J
    Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of calgranulin A and B in middle ear cholesteatoma].
    Holly A; Bujía J; Lempart K; Serge M
    Laryngorhinootologie; 1995 Jan; 74(1):33-5. PubMed ID: 7888019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
    Shinoda H; Huang CC
    Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and significance of TERT and c-Myc oncogene protein product on cholesteatoma epithelium].
    Zhang F; Liu J; Yuan T; Liu Q; Han Z; Wang S; Zhang C; Chen S
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):302-4. PubMed ID: 16001896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium.
    Kojima H; Miyazaki H; Tanaka Y; Shiwa M; Koga T; Moriyama H
    Arch Otolaryngol Head Neck Surg; 1999 Jul; 125(7):738-42. PubMed ID: 10406309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.
    Sudhoff H; Bujía J; Fisseler-Eckhoff A; Holly A; Schulz-Flake C; Hildmann H
    Laryngoscope; 1995 Nov; 105(11):1227-31. PubMed ID: 7475881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
    Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival signaling and terminal differentiation in cholesteatoma epithelium.
    Huisman MA; De Heer E; Grote JJ
    Acta Otolaryngol; 2007 Apr; 127(4):424-9. PubMed ID: 17453465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cycline-dependent kinase inhibitor, p27 (KIP1), is associated with cholesteatoma.
    Bayazít YA; Karakök M; Uçak R; Kanlíkama M
    Laryngoscope; 2001 Jun; 111(6):1037-41. PubMed ID: 11404617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autocrine growth mechanisms of cholesteatoma epithelium].
    Schilling V; Holly A; Bujía J; Schulz P
    Laryngorhinootologie; 1993 Jul; 72(7):319-23. PubMed ID: 8369082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study on proliferative activity of experimental cholesteatoma.
    Park K; Park HJ; Chun YM
    Eur Arch Otorhinolaryngol; 2001 Mar; 258(3):101-5. PubMed ID: 11374247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma.
    Bujía J; Holly A; Schilling V; Negri B; Pitzke P; Schulz P
    Laryngoscope; 1993 Mar; 103(3):326-9. PubMed ID: 7680089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical studies with middle ear mucosal remnants in cholesteatoma].
    Sudhoff H; Borkowski G; Bujia J; Hildmann H; Fisseler-Eckhoff A
    HNO; 1997 Aug; 45(8):630-5. PubMed ID: 9378670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The expression of Ras protein in human middle ear cholesteatoma].
    Xu Y; Jin K; Dong W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal differentiation of epithelial cells in middle ear cholesteatoma: investigation of patterns of expression of protein kinase C-delta and protein kinase C-eta.
    Miyazaki H; Kojima H; Tanaka Y; Shiwa M; Koga T; Moriyama H
    Laryngoscope; 1999 Nov; 109(11):1785-92. PubMed ID: 10569408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
    Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
    Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical basement membrane analysis of cholesteatoma epithelium].
    Lang S; Nerlich A; Wiest I; Schreiner M
    Laryngorhinootologie; 1994 Jul; 73(7):371-4. PubMed ID: 7916782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of caspase-14 in human middle ear cholesteatoma.
    Jung MH; Lee JH; Cho JG; Jung HH; Hwang SJ; Chae SW
    Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of c-MYC status in primary acquired cholesteatoma by using fluorescence in situ hybridization technique.
    Ozturk K; Yildirim MS; Acar H; Cenik Z; Keles B
    Otol Neurotol; 2006 Aug; 27(5):588-91. PubMed ID: 16868505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.